Covid Pill Could Pose Serious Risks
- Written by: Ragnar Danneskjöld
- Published in Coronavirus
www.barrons.com | Merck announced that its anitviral molnupiravir performed well in a trial of high-risk Covid-19 patients. However, some scientists are warning that the method it uses to kill the virus could be dangerous and limit the drugs usefullness.